Clinical Trials Browser

Phase 4 × Neuroendocrine Tumors × lanreotide × Clear all

NCT05701241 2024-06-14

SAUNA

Phase 4 Recruiting

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT03083210 2019-05-20

Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET

Phase 4 Unknown

Neuroendocrine Tumors